<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03887260</url>
  </required_header>
  <id_info>
    <org_study_id>ESPblockLumbotomy</org_study_id>
    <nct_id>NCT03887260</nct_id>
  </id_info>
  <brief_title>Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Nephrectomy/Nephron Sparing Surgery(NSS) Performed Via Lumbotomy</brief_title>
  <official_title>Clinical Effectiveness of Erector Spinae Plane Block in Peri-operative Analgesia for Nephrectomy/NSS Performed Via Lumbotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Warsaw Clinical University Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      42 patients age of 20 to 85, (ASA) physical status I-III undergoing nephrectomy/NSS
      procedures via lumbotomy in 1st Department of Anesthesiology in Warsaw will be enrolled in
      the study. Patients will be randomised into 2 groups - patients from the first group will
      undergo General Anesthesia (GA) with intravenous analgesia peri-operatively, patients from
      the second group will receive GA plus the Erector Spinae Plane Block (ESP block) unilaterally
      performed under ultrasound guidance with catheter left on the side of surgery. Ultrasound
      transducer will be placed in a longitudinal orientation 3 cm lateral to the Th7 spinous
      process. Three muscles will be identified superficial to the hyperechogenic transverse
      process shadow as follows: trapezius, rhomboid major, and erector spinae. An 8-cm 18-gauge
      block needle will be inserted in a cephalad-to-caudad direction until the tip gets in the
      interfascial plane between rhomboid major and erector spinae muscles, as evidenced by
      visualization of local anesthetic spreading in a linear pattern between erector spinae and
      the bony acoustic shadows of the transverse processes. . Patients in this group will be
      anesthetized with 20ml 0,25% bupivacaine + Adrenaline 1:200 000 via interfascial catheter.
      ESP block will be performed at the level of Th7-8 after proper positioning he patient in the
      sitting position before GA then standard technique of catheter application will be applied.
      After the surgery the elastomeric pump will be attached to the catheter with 0,125%
      bupivacaine with Adrenaline 1:200 000. Anaesthesia will be standardised In the both groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 20, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Morphine Requirements</measure>
    <time_frame>24 hours post surgery</time_frame>
    <description>Patient Controlled Analgesia (PCA) morphine consumption in both groups will be recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative Fentanyl Requirements</measure>
    <time_frame>Time of surgery.</time_frame>
    <description>Fentanyl consumption in both groups will be recorded ( ug of fentanyl given intraoperatively divided by patients weight in kg and minutes of surgery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Nausea and Vomiting (PONV) PONV PONV</measure>
    <time_frame>24 hours post surgery</time_frame>
    <description>Postoperative nausea and vomiting will be recorded if occurred</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Erector Spinae Plane Block</condition>
  <arm_group>
    <arm_group_label>GA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive general anaesthesia for nephrectomy/NSS procedures via lumbotomy. Analgesia will be provided by titration of fentanyl during surgery. An intravenous patient controlled morphine pump will be used postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ESP group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive general anaesthesia with ESP block for nephrectomy/NSS procedures via lumbotomy. Catheter will be inserted in the erector spinae plane on the side of surgery. Postoperatively patients will get continuous infusion of 0,125% Bupivacaine+Adrenaline to the catheter for 24h and PCA morphine pump intravenously.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine PCA pump</intervention_name>
    <description>Morphine given postoperatively.</description>
    <arm_group_label>ESP group</arm_group_label>
    <arm_group_label>GA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ESP block</intervention_name>
    <description>Regional anaesthesia technique performed under ultrasound guidance before surgery</description>
    <arm_group_label>ESP group</arm_group_label>
    <other_name>ESP block performed with 0,25% Marcaine+Adrenaline 1:200 000</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Fentanyl administration during procedure, calculated per patient's weight and duration of surgery (minutes).</description>
    <arm_group_label>ESP group</arm_group_label>
    <arm_group_label>GA group</arm_group_label>
    <other_name>Fentanyl administration during surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pts undergoing nephrectomy/NSS procedures via lumbotomy in 1st Department of
             Anaesthesiology in Warsaw

          -  Pts consented for the study prior to surgery

          -  ASA 1-3

        Exclusion Criteria:

          -  Pts without consent for trial

          -  Pts ASA 4-5

          -  Coagulation abnormalities

          -  Allergy to local anesthetics

          -  Skin lesions in the place of needle insertion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anna Roziewska</last_name>
    <phone>48 606932992</phone>
    <email>anna.roziewska@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lidia Jureczko</last_name>
    <phone>48 501054419</phone>
    <email>jureczko@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Warsaw Clinical University Center</name>
      <address>
        <city>Warsaw</city>
        <zip>02-005</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Roziewska</last_name>
      <phone>48606932992</phone>
      <email>anna.roziewska@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>March 11, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2019</study_first_posted>
  <last_update_submitted>March 21, 2019</last_update_submitted>
  <last_update_submitted_qc>March 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

